1
|
Theochari I, Papadimitriou V, Papahatjis D, Assimomytis N, Pappou E, Pratsinis H, Xenakis A, Pletsa V. Oil-In-Water Microemulsions as Hosts for Benzothiophene-Based Cytotoxic Compounds: An Effective Combination. Biomimetics (Basel) 2018; 3:biomimetics3020013. [PMID: 31105235 PMCID: PMC6352693 DOI: 10.3390/biomimetics3020013] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2018] [Revised: 06/07/2018] [Accepted: 06/12/2018] [Indexed: 01/07/2023] Open
Abstract
Targeted delivery of chemotherapeutics in order to overcome side effects and enhance chemosensitivity remains a major issue in cancer research. In this context, biocompatible oil-in-water (O/W) microemulsions were developed as matrices for the encapsulation of DPS-2 a benzothiophene analogue, exhibiting high cytotoxicity in various cancer cell lines, among them the MW 164 skin melanoma and Caco-2 human epithelial colorectal adenocarcinoma cell lines. The microemulsion delivery system was structurally characterized by dynamic light scattering (DLS) and electron paramagnetic resonance (EPR) spectroscopy. The effective release of a lipophilic encapsulated compound was evaluated via confocal microscopy. The cytotoxic effect, in the presence and absence of DPS-2, was examined through the thiazolyl blue tetrazolium bromide (MTT) cell proliferation assay. When encapsulated, DPS-2 was as cytotoxic as when dissolved in dimethyl sulfoxide (DMSO). Hence, the oil cores of O/W microemulsions were proven effective biocompatible carriers of lipophilic bioactive molecules in biological assessment experiments. Further investigation through fluorescence-activated cell sorting (FACS) analysis, comet assay, and Western blotting, revealed that DPS-2, although non-genotoxic, induced S phase delay accompanied by cdc25A degradation and a nonapoptotic cell death in both cell lines, which implies that this benzothiophene analogue is a deoxyribonucleic acid (DNA) replication inhibitor.
Collapse
Affiliation(s)
- Ioanna Theochari
- Institute of Biology, Medicinal Chemistry & Biotechnology, National Hellenic Research Foundation, 48 Vassileos Constantinou Avenue, 11635 Athens, Greece; (I.T.); (V.Pa.); (D.P.); (N.A.); (E.P.); (A.X.)
- Department of Biochemistry and Biotechnology, School of Health Sciences, University of Thessaly, Viopolis, 41500 Larissa, Greece
| | - Vassiliki Papadimitriou
- Institute of Biology, Medicinal Chemistry & Biotechnology, National Hellenic Research Foundation, 48 Vassileos Constantinou Avenue, 11635 Athens, Greece; (I.T.); (V.Pa.); (D.P.); (N.A.); (E.P.); (A.X.)
| | - Demetris Papahatjis
- Institute of Biology, Medicinal Chemistry & Biotechnology, National Hellenic Research Foundation, 48 Vassileos Constantinou Avenue, 11635 Athens, Greece; (I.T.); (V.Pa.); (D.P.); (N.A.); (E.P.); (A.X.)
| | - Nikos Assimomytis
- Institute of Biology, Medicinal Chemistry & Biotechnology, National Hellenic Research Foundation, 48 Vassileos Constantinou Avenue, 11635 Athens, Greece; (I.T.); (V.Pa.); (D.P.); (N.A.); (E.P.); (A.X.)
| | - Efthimia Pappou
- Institute of Biology, Medicinal Chemistry & Biotechnology, National Hellenic Research Foundation, 48 Vassileos Constantinou Avenue, 11635 Athens, Greece; (I.T.); (V.Pa.); (D.P.); (N.A.); (E.P.); (A.X.)
| | - Harris Pratsinis
- Laboratory of Cell Proliferation and Ageing, Institute of Biosciences and Applications, National Centre of Scientific Research “Demokritos”, 11635 Athens, Greece;
| | - Aristotelis Xenakis
- Institute of Biology, Medicinal Chemistry & Biotechnology, National Hellenic Research Foundation, 48 Vassileos Constantinou Avenue, 11635 Athens, Greece; (I.T.); (V.Pa.); (D.P.); (N.A.); (E.P.); (A.X.)
| | - Vasiliki Pletsa
- Institute of Biology, Medicinal Chemistry & Biotechnology, National Hellenic Research Foundation, 48 Vassileos Constantinou Avenue, 11635 Athens, Greece; (I.T.); (V.Pa.); (D.P.); (N.A.); (E.P.); (A.X.)
- Correspondence: ; Tel.: +302-107-273-7541
| |
Collapse
|
2
|
Correction: Modulation of Pathways Underlying Distinct Cell Death Mechanisms in Two Human Lung Cancer Cell Lines in Response to SN1 Methylating Agents Treatment. PLoS One 2018. [PMID: 29518157 PMCID: PMC5843283 DOI: 10.1371/journal.pone.0194257] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
|